Policy news

AMI's policy team is one of the most active in the sector - read the latest news here.
Displaying 7 results
27 Mar 2023
Doing something scary every week

Professor James Ebdon reveals his experience of pitching bacteriophages to the Commons Science and Technology Committee.

15 Mar 2023
AMI young scientist turns spotlight on government science policy

Applied Microbiology International (AMI) member Shamik Roy was among a group of young scientists and engineers who quizzed government representatives at the Voice of the Future event this week.

03 Mar 2023
AMI welcomes prospect of Horizon re-entry following Brexit deal

Applied Microbiology International (AMI) has welcomed the EU Commission President’s recent mention of starting work on associating the UK to the €100bn (£88.6bn) Horizon Europe programme.

21 Feb 2023
Regulatory pathway needs to be developed to make the most of phages: AMI

A regulatory pathway needs to be developed if the UK is to reap the benefits of bacteriophage therapy, Applied Microbiology International (AMI) has warned.

23 Jan 2023
AMI pitches Government to develop pathway to phage therapy

Applied Microbiology International is urging the UK Government to launch an inquiry to explore the regulatory barriers and opportunities for bacteriophage therapy in the UK, in order to explore their potential as an alternative or addition to conventional antimicrobial drugs.

23 Jan 2023
AMI’s pitch on bacteriophages is winner of My Science Inquiry

Applied Microbiology International’s pitch to explore bacteriophages as an alternative to antimicrobial drugs has been selected by the Commons Science and Technology Committee as the winner of the My Science inquiry.

29 Nov 2022
AMI holds roundtable to discuss UK's AMR 5-year National Action Plan

On 29 November 2022, AMI held a roundtable with policy experts on the next steps for the UK with regards to AMR.